Vigilant Biosciences Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Vigilant Biosciences General Information
Description
Developer of a diagnostic test kit designed to aid in the early detection and intervention of oral and oropharyngeal cancer. The company's test kit measures total protein levels and assess the level of tumor-initiating and stem cell-associated biomarker in the body, enabling healthcare professionals to accurately detect oral cancer before any visual or physical indicators appear.
Contact Information
Website
www.vigilantbiosciences.comCorporate Office
- 1008 Ranch Road 620
- Suite 204
- Lakeway, TX 78734
- United States
Corporate Office
- 1008 Ranch Road 620
- Suite 204
- Lakeway, TX 78734
- United States
Vigilant Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 03-May-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 25-Nov-2019 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 4. Grant | 11-Aug-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B2) | 11-Jul-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 24-Feb-2015 | $5.5M | $7.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 25-Mar-2014 | $2.3M | $2.3M | Completed | Generating Revenue |
Vigilant Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B4 | ||||||||
| Series B2 | ||||||||
| Series B | 18,861 | $0.001000 | 8% | $298.42 | $298.42 | 1x | $298.42 | 9.1% |
| Series A | 16,000 | $0.001000 | 8% | $125 | $125 | 1x | $125 | 7.72% |
Vigilant Biosciences Comparisons
Industry
Financing
Details
Vigilant Biosciences Competitors (20)
One of Vigilant Biosciences’s 20 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| Boreal Genomics | Formerly VC-backed | Vancouver, Canada | ||||
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA |
Vigilant Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vigilant Biosciences Patents
Vigilant Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4605748-A1 | Methods and compositions for oral cancer risk | Pending | 17-Oct-2022 | ||
| US-20250327804-A1 | Methods and compositions for oral cancer risk | Pending | 17-Oct-2022 | ||
| WO-2024086159-A1 | Methods and compositions for oral cancer risk | Inactive | 17-Oct-2022 | ||
| US-11150246-B2 | Device for early detection of disease states | Inactive | 11-Sep-2015 | ||
| US-20180252716-A1 | Device for early detection of disease states | Active | 11-Sep-2015 | G01N33/575 |
Vigilant Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vigilant Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novalis LifeSciences | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Tidepool Labs | Accelerator/Incubator | Minority | ||
| National Institute of Dental and Craniofacial Research | Government |
Vigilant Biosciences FAQs
-
When was Vigilant Biosciences founded?
Vigilant Biosciences was founded in 2011.
-
Where is Vigilant Biosciences headquartered?
Vigilant Biosciences is headquartered in Lakeway, TX.
-
What is the size of Vigilant Biosciences?
Vigilant Biosciences has 20 total employees.
-
What industry is Vigilant Biosciences in?
Vigilant Biosciences’s primary industry is Diagnostic Equipment.
-
Is Vigilant Biosciences a private or public company?
Vigilant Biosciences is a Private company.
-
What is Vigilant Biosciences’s current revenue?
The current revenue for Vigilant Biosciences is .
-
How much funding has Vigilant Biosciences raised over time?
Vigilant Biosciences has raised $32.5M.
-
Who are Vigilant Biosciences’s investors?
Novalis LifeSciences, , Tidepool Labs, and National Institute of Dental and Craniofacial Research have invested in Vigilant Biosciences.
-
Who are Vigilant Biosciences’s competitors?
Hain Lifescience, Boreal Genomics, CirculoGene, Decipher Urologic Cancers, and Foundation Medicine are some of the 20 competitors of Vigilant Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
